Arch Venture Partners
About
ARCH Venture Partners is a Chicago-based venture capital firm focused on seed and early-stage investments in life sciences, deep science, and information technology. With over $12 billion in assets under management and 30 years of biotech investing, ARCH co-founds breakthrough companies and provides long-term patient capital to transform scientific discoveries into industry-defining businesses.
Key facts
At-a-glance profile data
- Website
- archventure.com
- Type
- Venture Capital
- Headquarters
- United States
- Portfolio companies
- 1
- Stages
- Series ASeries B
- Cheque size
- $10M to $10.0B
- Sector focus
- Life SciencesBiotechnologyDeep TechHealthcareInformation Technology
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 3 Sept 2025 | Treeline Biosciences | Series B | $200M |
| 16 Dec 2022 | Synchron | Undisclosed round | $75M |
“The backers: Bezos personally, JPMorgan, BlackRock, Goldman Sachs, DST Global, and Arch Venture Partners. The mission: do for engineering and manufacturing what large language models did for text. Bezos is calling it an "artificial general…”
View on Reddit“Mental health startup focused on seniors launches with $32M, backing from Arch Venture Partners.”
View on Reddit“Mental health startup focused on seniors launches with $32M, backing from Arch Venture Partners.”
View on Reddit“ARCH Venture Partners raises close to $3B for early-stage biotech fund.”
View on Reddit“ARCH Venture Partners raises close to $3B for early-stage biotech fund.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
Frequently asked
What companies has Arch Venture Partners invested in?
Arch Venture Partners has invested in Treeline Biosciences, Synchron.